Clin2
NCT07291375Possibly a fitNot yet recruiting

Amlodipine to protect kidneys after contrast dye

Contrast-induced Nephropathy

Treatments studied

Part of Heart & circulation, Kidney & urinary clinical trials.

This trial tests if amlodipine, a blood pressure medication, can help protect the kidneys from damage caused by contrast dye used in imaging tests. Participation may help reduce the risk of kidney injury after a contrast procedure.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
40 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have diabetes.
  • Your kidney function is normal (serum creatinine less than 1.2).
  • You do not have high blood pressure.
  • You are not bedridden or unable to take food or drink by mouth (NPO).
  • You do not have chronic kidney disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06695429Recruiting
Beetroot juice to prevent kidney damage from contrast dye

This trial tests if drinking beetroot juice can help protect your kidneys from damage caused by the dye used during heart procedures. It is for people hospitalized with a certain type of heart attack who are at moderate to high risk of kidney problems.

Cartagena
NCT07459413Recruiting
Drinking vs. IV fluids to protect kidneys from contrast dye

This trial compares drinking fluids by mouth versus receiving fluids through an IV to prevent kidney injury from CT contrast dye. It may be a good option if you have mild to moderate kidney disease and need a contrast CT while in the emergency department.

Istanbul, Gaziosmanpasa
NCT05283512Recruiting
IV versus drink fluids to protect kidneys after CT scan

This study compares giving fluids through a vein versus drinking fluids to lower the risk of sudden kidney injury after a CT scan with contrast dye. It focuses on adults with very poor kidney function who are scheduled for an elective CT scan.

Odense C, Fyn
NCT07016074Recruiting· Phase 2
Nitrate to prevent kidney injury from contrast dye

This trial tests whether a simple inorganic nitrate pill can protect your kidneys from damage caused by contrast dye used in heart catheterization or CT scans. It is for people whose kidneys are already somewhat weak, making them at higher risk for this type of injury.

Ann Arbor, Michigan
NCT04279457Recruiting· Phase 4
Test whether special dye helps protect kidney function during heart procedures

This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.

Charleston, West Virginia
NCT07761754Not yet recruiting
Preventing kidney damage with fluids during heart attack treatment

This study tests whether giving extra fluids by mouth before and during a common heart procedure (primary angioplasty) can reduce the risk of kidney damage caused by the contrast dye used during the procedure. If you have had a heart attack and are scheduled for this procedure, this trial may help protect your kidneys.

Hear when a new Contrast-induced Nephropathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.